SeaSpine Attracting New Surgeons and Distributors in 2022

SeaSpine reported 1Q22 orthopedic sales of $50.7 million, +20.8% compared to 1Q21.

The company said that COVID-related headwinds had a significant impact in January, but quickly recovered in February. SeaSpine believes most of its surgeons are back to "typical" waitlist periods of two to three months.

To date, SeaSpine has closed four...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

ME

Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.



Contact Us

0